new semaglutide medication Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients FDA warns about compounded versions

Saxenda Dosing Saxenda requires daily subcutaneous injection: Titration schedule: Administration: Inject once daily at any time Consistent timing recommended Abdomen, thigh, or upper arm injection sites Rotate sites to prevent irritation Practical burden: 365 injections per year Must remember daily More needle/supply use Higher chance of missed doses Semaglutide Dosing Semaglutide requires weekly subcutaneous injection: Titration schedule (Wegovy doses): Administration: Inject once weekly on the same day each week Any time of day Same injection sites as Saxenda Rotate sites Practical burden: 52 injections per year Weekly reminder easier than daily Less needle/supply use Better adherence typically Dosing Comparison Impact on Adherence Research consistently shows better adherence with weekly versus daily medications: Daily dosing challenges: Easier to forget More disruption to routines Higher cumulative burden Greater chance of inconsistent dosing Weekly dosing advantages: Easier to remember one day Less intrusion on daily life Can establish reliable routine Fewer opportunities to miss doses Better adherence translates to better real-world results

Several employees have sued health insurance companies for excluding coverage of GLP-1 medications prescribed solely to treat obesity, arguing that such obesity exclusion constitutes disability discrimination under the ACA

Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients

Is retatrutide dosing weight-based

Both IGF-I and IGF-II signal through the tyrosine kinase type I receptor (IGF-IR), but IGF-II can also signal through the IGF-II/Mannose-6-phosphate receptor